BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mathonnet M, Descottes B, Valleix D, Labrousse F, Truffinet V, Denizot Y. Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma. World J Gastroenterol 2006; 12(23): 3782-3783 [PMID: 16773701 DOI: 10.3748/wjg.v12.i23.3782]
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3782.htm
Number Citing Articles
1
A. R. Rama, A. Aguilera, C. Melguizo, O. Caba, J. Prados. Tissue Specific Promoters in Colorectal CancerDisease Markers 2015; 2015: 1 doi: 10.1155/2015/390161
2
Dong-Xun Zhou, Long-Yi Zheng, Hai-Xia Qu, Feng-Hai Yu, Shan-Shan Zou, Yi Hong, Ye-Xiong Tan, Hao Wang, He-Ping Hu, Hong-Yang Wang. Identification and differential expression of human carcinoma-associated antigens in hepatocellular carcinoma tissuesExperimental Biology and Medicine 2013; 238(2): 167 doi: 10.1177/1535370212474599
3
Feng DUAN, Mao Qiang WANG, Feng Yong LIU, Zhi Jun WANG, Peng SONG, Yan WANG. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasisAsia-Pacific Journal of Clinical Oncology 2012; 8(2): 156 doi: 10.1111/j.1743-7563.2012.01542.x
4
Leida Zhang, Peng Hu, Xi Chen, Ping Bie, Lian-Yue Yang. Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-AnalysisPLoS ONE 2014; 9(6): e100305 doi: 10.1371/journal.pone.0100305
5
Zhoujing Cheng, Lin He, Yingjie Guo, Yuhua Song, Shasha Song, Lijiu Zhang. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysisWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02017-0
6
Wei Bai, Yong Ji Wang, Yan Zhao, Xing Shun Qi, Zhan Xin Yin, Chuang Ye He, Rui Jun Li, Kai Chun Wu, Jie Lai Xia, Dai Ming Fan, Guo Hong Han. Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching studyJournal of Digestive Diseases 2013; 14(4): 181 doi: 10.1111/1751-2980.12038
7
Bo Zhou, Zhiping Yan, Rong Liu, Peng Shi, Sheng Qian, Xudong Qu, Liang Zhu, Wei Zhang, Jianhua Wang. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular CarcinomaRadiology 2016; 280(2): 630 doi: 10.1148/radiol.2016150719
8
Yunxia Yuan, Huichun Yu, Yong Yin. A highly sensitive aptasensor for vascular endothelial growth factor based on fluorescence resonance energy transfer from upconversion nanoparticles to MoS2 nanosheetsAnalytical Methods 2020; 12(36): 4466 doi: 10.1039/D0AY01067G
9
Jing Chen, Chengya Zhou, Yu Long, Xude Yin. Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching studyTumor Biology 2015; 36(1): 183 doi: 10.1007/s13277-014-2608-3
10
Yves Denizot, Rafael De Armas, François Caire, Jean Jacques Moreau, Isabelle Pommepuy, Véronique Truffinet, François Labrousse. The Quantitative Analysis of bFGF and VEGF by ELISA in Human MeningiomasMediators of Inflammation 2006; 2006(1) doi: 10.1155/MI/2006/36376
11
Magda Nasr, Eman Selima, Omar Hamed, Amany Kazem. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in miceEuropean Journal of Pharmacology 2014; 723: 267 doi: 10.1016/j.ejphar.2013.11.022
12
YONGXU MU, JUNFENG HE, RUIQIANG YAN, XIAOYAN HU, HAIYAN LIU, ZHIMING HAO. IGF-1 and VEGF can be used as prognostic indicators for patients with uterine fibroids treated with uterine artery embolizationExperimental and Therapeutic Medicine 2016; 11(2): 645 doi: 10.3892/etm.2015.2924
13
Wenjiao Zeng, Annette S.H. Gouw, Marius C. van den Heuvel, Peter J. Zwiers, Pieter E. Zondervan, Sibrand Poppema, Nong Zhang, Inge Platteel, Koert P. de Jong, Grietje Molema. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularizationHepatology 2008; 48(5): 1517 doi: 10.1002/hep.22490